The Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size is estimated to be worth US$ 3665.8 million in 2021 and is forecast to a readjusted size of USD 6128.6 million by 2028 with a CAGR of 7.6% during review period. Hospitals accounting for % of the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Real Time PCR segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics include Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy, and Roche Diagnostics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Real Time PCR
DNA/RNA Purification
Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by players, this report covers
Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with revenue, gross margin and global market share of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics from 2019 to 2022.
Chapter 3, the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
1.2 Classification of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Type
1.2.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Type in 2021
1.2.3 Real Time PCR
1.2.4 DNA/RNA Purification
1.3 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Application
1.3.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size & Forecast
1.5 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast by Region
1.5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
1.6.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
1.6.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
2.1.4 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Atlas Genetics
2.2.1 Atlas Genetics Details
2.2.2 Atlas Genetics Major Business
2.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
2.2.4 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Atlas Genetics Recent Developments and Future Plans
2.3 Cepheid
2.3.1 Cepheid Details
2.3.2 Cepheid Major Business
2.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
2.3.4 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Cepheid Recent Developments and Future Plans
2.4 Fluxergy
2.4.1 Fluxergy Details
2.4.2 Fluxergy Major Business
2.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
2.4.4 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Fluxergy Recent Developments and Future Plans
2.5 Roche Diagnostics
2.5.1 Roche Diagnostics Details
2.5.2 Roche Diagnostics Major Business
2.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
2.5.4 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Roche Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2021
3.2.2 Top 10 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Head Office, Products and Services Provided
3.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Mergers & Acquisitions
3.5 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2028)
6.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2028)
6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
6.3.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2028)
7.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2028)
7.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
7.3.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region
8.3.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Region (2017-2028)
8.3.2 China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2028)
9.2 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2028)
9.3 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
9.3.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
10.3.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
Table 9. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Atlas Genetics Corporate Information, Head Office, and Major Competitors
Table 11. Atlas Genetics Major Business
Table 12. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
Table 13. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Cepheid Corporate Information, Head Office, and Major Competitors
Table 15. Cepheid Major Business
Table 16. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
Table 17. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Fluxergy Corporate Information, Head Office, and Major Competitors
Table 19. Fluxergy Major Business
Table 20. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
Table 21. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. Roche Diagnostics Major Business
Table 24. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
Table 25. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 27. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 28. Breakdown of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Head Office, Products and Services Provided
Table 30. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Mergers & Acquisitions in the Past Five Years
Table 31. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics New Entrants and Expansion Plans
Table 32. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 33. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Type (2017-2022)
Table 34. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Forecast by Type (2023-2028)
Table 35. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022)
Table 36. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Forecast by Application (2023-2028)
Table 37. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 38. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 39. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 40. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 41. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 42. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 43. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 44. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 45. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 46. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 47. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 48. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 49. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 50. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 51. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 52. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 53. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 54. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 55. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 56. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 57. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 58. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 59. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 60. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 61. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 62. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 63. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 64. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 65. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 66. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Picture
Figure 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Type in 2021
Figure 3. Real Time PCR
Figure 4. DNA/RNA Purification
Figure 5. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 12. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Region in 2021
Figure 13. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
Figure 19. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
Figure 20. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Atlas Genetics Recent Developments and Future Plans
Figure 23. Cepheid Recent Developments and Future Plans
Figure 24. Fluxergy Recent Developments and Future Plans
Figure 25. Roche Diagnostics Recent Developments and Future Plans
Figure 26. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players in 2021
Figure 27. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 28. Global Top 3 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share in 2021
Figure 29. Global Top 10 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share in 2021
Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 31. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Type in 2021
Figure 32. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Type (2023-2028)
Figure 33. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Application in 2021
Figure 34. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Application (2023-2028)
Figure 35. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Type (2017-2028)
Figure 36. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Application (2017-2028)
Figure 37. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 38. United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Type (2017-2028)
Figure 42. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Application (2017-2028)
Figure 43. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 44. Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Type (2017-2028)
Figure 50. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Application (2017-2028)
Figure 51. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Region (2017-2028)
Figure 52. China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Type (2017-2028)
Figure 59. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Application (2017-2028)
Figure 60. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 61. Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Type (2017-2028)
Figure 64. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Sales Market Share by Application (2017-2028)
Figure 65. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Market Share by Country (2017-2028)
Figure 66. Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Methodology
Figure 70. Research Process and Data Source